do-me/EUR-LEX huggingface dataset:
Corrigendum to Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2016 to 31 March 2016 (OJ C 154, 29.4.2016)
Date: 2016-08-26
Institutions: European Commission
Subjects: drug surveillance, market approval, marketing standard, medicinal product, withdrawal from the market








C_2016312EN.01002201.xml










26.8.2016   


EN


Official Journal of the European Union


C 312/22





Corrigendum to Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2016 to 31 March 2016

(
Official Journal of the European Union C 154 of 29 April 2016
)

(2016/C 312/03)
On page 6:

for:







‘—



Suspension of a marketing authorisation (Article 20 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)













Date of the decision


Name of the medicinal product


Holder of the marketing authorisation


Number of the entry in the Community Register


Date of notification




23.3.2016


Zydelig


Gilead Sciences International Limited
Cambridge CB21 6GT, United Kingdom


EU/1/14/938


30.3.2016’





read:







‘—



Modification of a marketing authorisation (Article 20 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)













Date of the decision


Name of the medicinal product


Holder of the marketing authorisation


Number of the entry in the Community Register


Date of notification




23.3.2016


Zydelig


Gilead Sciences International Limited
Cambridge CB21 6GT, United Kingdom


EU/1/14/938


30.3.2016’
Non-opposition to a notified concentration (Case M.8122 — SEGRO/PSPIB/SELP/Pusignan-DC1) (Text with EEA relevance)
Date: 2016-08-26
Institutions: European Commission
Subjects: economic concentration, logistics, merger control, real estate business








C_2016311EN.01000101.xml










26.8.2016   


EN


Official Journal of the European Union


C 311/1





Non-opposition to a notified concentration
(Case M.8122 — SEGRO/PSPIB/SELP/Pusignan-DC1)
(Text with EEA relevance)
(2016/C 311/01)
On 19 August 2016, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in the English language and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32016M8122. EUR-Lex is the online access to the European law.






(1)  OJ L 24, 29.1.2004, p. 1.